0500B |
Barbital, Blood |
0500SP |
Barbital, Serum/Plasma |
0500U |
Barbital, Urine |
0512B |
Barbiturates Screen, Blood |
0512SP |
Barbiturates Screen, Serum/Plasma |
0512U |
Barbiturates Screen, Urine |
0610B |
Benzphetamine as Metabolites, Blood |
0610SP |
Benzphetamine as Metabolites, Serum/Plasma |
0610U |
Benzphetamine as Metabolites, Urine |
0771B |
Brorphine, Blood |
0771SP |
Brorphine, Serum/Plasma |
0771U |
Brorphine, Urine |
0810B |
Butabarbital, Blood |
0810SP |
Butabarbital, Serum/Plasma |
0810U |
Butabarbital, Urine |
0830B |
Butalbital, Blood |
0830SP |
Butalbital, Serum/Plasma |
0830U |
Butalbital, Urine |
2626B |
Bath Salts Panel (Qualitative), Blood |
2626SP |
Bath Salts Panel (Qualitative), Serum/Plasma |
2626U |
Bath Salts Panel (Qualitative), Urine |
6921H |
Barbiturates Screen, Hair |
8620B |
Barbiturates Panel, Blood |
8620FL |
Barbiturates Panel, Fluid |
8620ME |
Barbiturates Panel (Qualitative), Meconium |
8620SP |
Barbiturates Panel, Serum/Plasma |
8620TI |
Barbiturates Panel, Tissue |
8620U |
Barbiturates Panel, Urine |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |